LawFinder.news
LawFinder.news

NCLAT Sets Aside Insolvency Proceedings Against FTF Pharma, Citing Pre-Existing Dispute

LAW FINDER NEWS NETWORK | |
NCLAT Sets Aside Insolvency Proceedings Against FTF Pharma, Citing Pre-Existing Dispute

Tribunal Rules Operational Creditor's Section 9 Application Invalid Due to Genuine Contractual Disputes Raised Prior to Demand Notice


In a significant ruling impacting insolvency jurisprudence, the National Company Law Appellate Tribunal (NCLAT), Principal Bench, New Delhi, on November 4, 2026, set aside the Corporate Insolvency Resolution Process (CIRP) initiated against FTF Pharma Private Limited, a pharmaceutical company, by Immacule Lifesciences Private Limited, an operational creditor.


The appeal was filed by Mr. Abhay Sapre, the suspended director of FTF Pharma, challenging the admission of the Section 9 application by the National Company Law Tribunal (NCLT), Ahmedabad Bench. The operational creditor had filed the application claiming dues of Rs. 2.18 crore, comprising three invoices raised under a Technology Transfer Agreement (TTA) executed between the parties in May 2022. The disputed invoices included charges for third-party laboratory testing and milestone payments linked with stability data essential for the product development.


FTF Pharma contended that a plausible and genuine pre-existing dispute existed before the issuance of the statutory demand notice dated October 22, 2024. The dispute centered around the contractual obligations under the TTA, including:


  • The scope of work and responsibility for laboratory testing costs;
  • Delays and incompleteness in the provision of three-month and six-month stability data required for milestone payments;
  • Concerns about the reliability of Out-of-Specification (OOS) test results and inadequate investigations thereof.


The corporate debtor presented extensive documentary evidence in the form of emails and correspondence dating back to 2023 and early 2024, wherein it had explicitly contested the liability for the claimed amounts well before the demand notice. These communications included detailed objections to invoices, requests for outstanding data, and instructions to halt project activities due to unresolved quality issues.


The NCLAT bench, comprising Justice Mohammad Faiz Alam Khan and Mr. Naresh Salecha, observed that the Adjudicating Authority (NCLT) erred in admitting the Section 9 application despite acknowledging the existence of pre-existing disputes. The Tribunal emphasized the binding legal principle, as laid down by the Supreme Court in Mobilox Innovations Pvt. Ltd. v. Kirusa Software Pvt. Ltd. (2018), that once a plausible pre-existing dispute is established, the application under Section 9 of the Insolvency and Bankruptcy Code, 2016, must be rejected. The NCLAT underscored that the Adjudicating Authority is not empowered to evaluate the merits or significance of the dispute at the admission stage.


Further, the Tribunal reiterated that the Insolvency and Bankruptcy Code is designed for insolvency resolution and not as a debt recovery mechanism, especially where the dues are disputed in good faith. The consequences of initiating CIRP, such as displacement of management and imposition of moratorium, are serious and should not be triggered by disputed claims.


Importantly, the operational creditor, Immacule Lifesciences, submitted an affidavit stating that all disputes and claims between the parties have been amicably resolved, and expressed no objection to the disposal of the appeal.


In its final decision, the NCLAT:


  • Set aside the NCLT order admitting the Section 9 application;
  • Closed the CIRP initiated against FTF Pharma Private Limited;
  • Directed cessation of the moratorium under Section 14;
  • Ordered the discharge of the Interim Resolution Professional and restoration of management powers to the Board of Directors;
  • Directed the handover of all assets, books, and records to the corporate debtor;
  • Mandated payment of IRP fees and adjustment of any sums paid by the operational creditor.


This ruling reiterates the judicial stance that insolvency proceedings cannot be misused as a tool for recovery of disputed dues and reinforces the need for operational creditors to ensure there is no pre-existing dispute before invoking the Code.


Bottom Line:

Insolvency and Bankruptcy Code, 2016 - Section 9 application by operational creditor is not maintainable where a plausible pre-existing dispute existed before issuance of demand notice - Adjudicating Authority cannot admit application by weighing significance of dispute or examining merits of contractual claims - IBC is not a recovery mechanism for disputed dues.


Statutory provision(s): Insolvency and Bankruptcy Code, 2016 Sections 5(6), 8, 9, 9(5)(ii)(d), 14, 61


Abhay Sapre v. Immacule Lifesciences Private Limited, (NCLAT)(Principal Bench, New Delhi) : Law Finder Doc Id # 3012742

Share this article: